Deepti Behl

9PUBLICATIONS
82CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jul 27, 2026
Real-World Tumor-Infiltrating Lymphocyte Therapy for Metastatic Melanoma: Treatment Delivery, Immune Reconstitution, and Cardiac Monitoring During High-Dose IL-2.

|May 13, 2026
Mitochondrial Imaging Detects Early Cardiac Changes Following Cancer Immunotherapy.

|Jan 15, 2026
Olaparib in Patients With Solid Tumors With ATM Alterations: Results From the Targeted Agent and Profiling Utilization Registry (TAPUR) Study.

Daniel R Carrizosa, Michael Rothe, Pam K Mangat

|Oct 16, 2024
Palbociclib in Patients With Head and Neck Cancer and Other Tumors With CDKN2A Alterations: Results From the Targeted Agent and Profiling Utilization Registry Study.

Francis P Worden, Evan Pisick, Michael Rothe

|Jul 16, 2024
Palbociclib in Patients With Soft Tissue Sarcoma With CDK4 Amplifications: Results From the Targeted Agent and Profiling Utilization Registry Study.

Scott Schuetze, Michael Rothe, Pam K Mangat

|May 15, 2024
Pertuzumab Plus Trastuzumab in Patients With Biliary Tract Cancer With ERBB2/3 Alterations: Results From the Targeted Agent and Profiling Utilization Registry Study.

Timothy L Cannon, Michael Rothe, Pam K Mangat

Pageof 2

Frequent Collaborators

7 joint publications

Pam K Mangat

7 joint publications

Elizabeth Garrett-Mayer

7 joint publications

Gina N Grantham

7 joint publications

Susan Halabi